Lisa Caperelli | Vice President of Investor Relations |
Bill Collier | President & Chief Executive Officer |
David Hastings | Chief Financial Officer |
Gaston Picchio | Chief Development Officer |
Mike Sofia | Chief Scientific Officer |
Roy Buchanan | JMP Securities |
Dennis Ding | Jefferies |
Brian Skorney | Baird |
Keay Nakae | Chardan |
Thomas Yip | H.C. Wainwright |
Good morning. My name is Abby and I will be your conference operator today. At this time, I would like to welcome everyone to the Arbutus Biopharma 2022 Second Quarter Financial Results and Corporate Update. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.